rs1632744
From SNPedia
Orientation | plus |
Stabilized | plus |
Make rs1632744(C;C) |
Make rs1632744(C;T) |
Make rs1632744(T;T) |
Reference | GRCh38 38.1/141 |
Chromosome | 5 |
Position | 104863359 |
is a | snp |
is | mentioned by |
dbSNP | rs1632744 |
dbSNP (classic) | rs1632744 |
ClinGen | rs1632744 |
ebi | rs1632744 |
HLI | rs1632744 |
Exac | rs1632744 |
Gnomad | rs1632744 |
Varsome | rs1632744 |
LitVar | rs1632744 |
Map | rs1632744 |
PheGenI | rs1632744 |
Biobank | rs1632744 |
1000 genomes | rs1632744 |
hgdp | rs1632744 |
ensembl | rs1632744 |
geneview | rs1632744 |
scholar | rs1632744 |
rs1632744 | |
pharmgkb | rs1632744 |
gwascentral | rs1632744 |
openSNP | rs1632744 |
23andMe | rs1632744 |
SNPshot | rs1632744 |
SNPdbe | rs1632744 |
MSV3d | rs1632744 |
GWAS Ctlg | rs1632744 |
GMAF | 0.4867 |
Max Magnitude | 0 |
? | (C;C) (C;T) (T;T) | 28 |
---|---|---|
|
GWAS snp | |
---|---|
PMID | [PMID 23648065![]() |
Trait | Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors) |
Title | Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan. |
Risk Allele | T |
P-val | 5E-6 |
Odds Ratio | 1.39 [0.959-2.007] |